Zydus Lifesciences
Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.
Launch date
Employees
Market cap
AUD23.7b
Enterprise valuation
AUD23.5b (Public information from Sep 2024)
Share price
INR1058.5 ZYDUSLIFE.NS
Ahmedabad Gujarat (HQ)
Corporate Venture Fund: Zynext Ventures
Financials
Estimates*
| INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 148.2b | 148.3b | 168.8b | 190.2b | 224.4b | 240.7b | 248.4b |
| % growth | 7 % | - | 14 % | 13 % | 18 % | 7 % | 3 % |
| EBITDA | 34.0b | 34.3b | 40.5b | 55.1b | 65.3b | 67.5b | 62.9b |
| % EBITDA margin | 23 % | 23 % | 24 % | 29 % | 29 % | 28 % | 25 % |
| Profit | 21.3b | 44.9b | 19.6b | 38.6b | 45.4b | 47.8b | 44.0b |
| % profit margin | 14 % | 30 % | 12 % | 20 % | 20 % | 20 % | 18 % |
| EV / revenue | 3.2x | 2.6x | 3.0x | 5.3x | 4.9x | 4.4x | 4.2x |
| EV / EBITDA | 14.0x | 11.3x | 12.4x | 18.3x | 16.9x | 15.8x | 16.5x |
| R&D budget | 1.2b | 1.1b | 1.4b | 1.6b | - | - | - |
| R&D % of revenue | 1 % | 1 % | 1 % | 1 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Zydus Lifesciences
Edit
ACQUISITION by Zydus Lifesciences Aug 2024
ACQUISITION by Zydus Lifesciences Oct 2023